International Stem Cell CORP
ISCONext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for ISCO. That does not mean none is planned.
Get an email about ISCO's next catalysts
Track International Stem Cell (ISCO) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 1 past
No catalysts found.
Market Overview
Stock performance and key metrics
Dapivirine Vaginal Ring-004
HIV Prevention
Ivermectin Topical Application Lotion
Head Lice
Permethrin
Scabies
Lozanoc
Neutropenia
GXCPC1
Knee Osteoarthritis
GXNPC1
Chronic Stroke
BOL-DP-o-04 + SCO
Low Back Pain
dapivirine
HIV Infections
Umbilical Cord Mesenchymal Stem Cell (UC-MSC)
Retinitis Pigmentosa
Dapivirine Vaginal Ring
Human Immunodeficiency Virus
dapivirine 4789
HIV-1 Infections
dapivirine (TMC120) vaginal gel
HIV Infections
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Dapivirine Vaginal Ring-004 | Phase 3 | HIV Prevention | - | - |
Ivermectin Topical Application Lotion | Phase 3 | Head Lice | - | - |
Permethrin | Phase 3 | Scabies | - | - |
Lozanoc | Phase 2 | Neutropenia | - | - |
GXCPC1 | Phase 2 | Knee Osteoarthritis | - | - |
GXNPC1 | Phase 2 | Chronic Stroke | - | - |
BOL-DP-o-04 + SCO | Phase 2 | Low Back Pain | - | - |
dapivirine | Phase 2 | HIV Infections | - | - |
Umbilical Cord Mesenchymal Stem Cell (UC-MSC) | Phase 2 | Retinitis Pigmentosa | - | - |
Dapivirine Vaginal Ring | Phase 2 | Human Immunodeficiency Virus | - | - |
dapivirine 4789 | Phase 2 | HIV-1 Infections | - | - |
dapivirine (TMC120) vaginal gel | Phase 2 | HIV Infections | - | - |
EGFR exon 20 mutated non-small cell lung cancer
1 drug in this indication
Advanced non-small cell lung cancer (NSCLC)
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in International Stem Cell CORP's drug pipeline?→
CatalystAlert tracks 12 drug candidates in International Stem Cell CORP's (ISCO) pipeline across Phase 3, Phase 2. Its lead program is Dapivirine Vaginal Ring-004 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is International Stem Cell CORP's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for International Stem Cell CORP (ISCO) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track ISCO biotech catalysts?→
Add ISCO to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow International Stem Cell CORP's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.